Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 22 11 2021
accepted: 19 05 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

There is an excessive burden of diabetes complications in low-resource settings. We conducted a systematic review to determine the nature and frequency of diabetes complications in newly diagnosed with type 2 diabetes. A systematic search was performed using Medline, CINAHL and Global Health online databases from inception to July 2020. Articles reporting prevalence of microvascular or macrovascular complications within six months of type 2 diabetes diagnosis and published in English or French from low- and middle-income countries (LMICs) were eligible for analysis. Data were extracted using a standardized data extraction tool. Descriptive statistics were used to describe the prevalence of micro and macrovascular complications in newly diagnosed type 2 diabetes. Assessment of heterogeneity was conducted using the inconsistency index (I2) and Cochran-Q chi2 statistical tests. Publication bias was assessed by the Funnel plot and Egger test. A total of 3 292 records underwent title or abstract screening and 95 articles underwent full text review. Thirty-three studies describing 13 283 participants (aged 20 years and older) met the inclusion criteria. The eligible studies were from Asia (n = 24), Africa (n = 4), Oceania (n = 2), South America (n = 2) and the Caribbean (n = 1). For microvascular complications, the median prevalence (interquartile range) of retinopathy, nephropathy and neuropathy were 12% (6%-15%), 15% (7%-35%) and 16% (10%25%) respectively. For macrovascular complications, the median prevalence (interquartile range) was 10% (7%-17%) for ischaemic heart disease, 6% (1%-20%) for peripheral arterial disease and 2% (1%-4%) for stroke. There was evidence of substantial heterogeneity between studies for all outcomes (I2 > 90%. We found a high prevalence of complications in newly diagnosed type 2 diabetes in LMICs. Findings suggest that many people live with diabetes and are only diagnosed when they present with complications in LMICs. Research is needed to guide timely and effective identification of people living with diabetes in these settings.

Identifiants

pubmed: 36962416
doi: 10.1371/journal.pgph.0000599
pii: PGPH-D-21-01000
pmc: PMC10021817
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000599

Informations de copyright

Copyright: © 2022 Aikaeli et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors declared that no competing interests exist.

Références

J Indian Med Assoc. 2008 Feb;106(2):92, 94-8
pubmed: 18705251
BMJ. 2015 Mar 16;350:h1435
pubmed: 25778910
J Pak Med Assoc. 2008 Oct;58(10):557-61
pubmed: 18998309
J Evid Based Med. 2017 Dec 21;:
pubmed: 29266844
Diabetes Care. 1994 Dec;17(12):1422-7
pubmed: 7882811
Diabetes Care. 1997 Sep;20(9):1435-41
pubmed: 9283793
Diabetes Res Clin Pract. 1998 Nov;42(2):131-9
pubmed: 9886750
J Assoc Physicians India. 2014 Aug;62(8):682-4
pubmed: 25856935
Am J Epidemiol. 1998 Mar 1;147(5):448-57
pubmed: 9525531
Diabetologia. 2019 Jan;62(1):3-16
pubmed: 30171279
Diabetes Metab Res Rev. 2010 Sep;26(6):481-9
pubmed: 20661939
Diabet Med. 2005 Mar;22(3):332-5
pubmed: 15717883
N Engl J Med. 2011 Mar 03;364(9):829-841
pubmed: 21366474
Diabetologia. 1997 Aug;40(8):953-8
pubmed: 9267991
J Pak Med Assoc. 2019 Mar;69(3):306-312
pubmed: 30890819
Diab Vasc Dis Res. 2019 Jul;16(4):344-350
pubmed: 30786752
BMJ Open Diabetes Res Care. 2020 Apr;8(1):
pubmed: 32332069
Global Health. 2018 Jan 16;14(1):3
pubmed: 29338746
Ann Fam Med. 2013 Jan-Feb;11(1):20-7
pubmed: 23319502
J Diabet Complications. 1991 Jan-Mar;5(1):1-5
pubmed: 1830312
Nephron. 2001 Mar;87(3):223-30
pubmed: 11287757
Indian J Endocrinol Metab. 2012 Sep;16(5):759-63
pubmed: 23087860
Afr J Med Med Sci. 2004 Mar;33(1):19-22
pubmed: 15490788
Diabetes Res Clin Pract. 2008 Jun;80(3):455-62
pubmed: 18294723
J Diabetes Complications. 2012 Mar-Apr;26(2):123-8
pubmed: 22446033
Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):114-8
pubmed: 26904479
World J Diabetes. 2015 Jun 25;6(6):850-67
pubmed: 26131326
Kidney Int. 2003 Jan;63(1):225-32
pubmed: 12472787
J Diabetes Res. 2015;2015:587673
pubmed: 26090473
Diabetes Care. 1995 Aug;18(8):1140-9
pubmed: 7587849
Diabetes Care. 2004 Sep;27(9):2120-8
pubmed: 15333472
Acta Ophthalmol. 2009 May;87(3):270-4
pubmed: 18823287
Invest Ophthalmol Vis Sci. 2013 Oct 17;54(10):6827-33
pubmed: 24065813
J Diabetes Complications. 2018 Jan;32(1):34-40
pubmed: 29107454
Diabetes Care. 2003 Sep;26(9):2604-8
pubmed: 12941726
Diabetologia. 2012 Sep;55(9):2335-42
pubmed: 22688348
Int J Chronic Dis. 2014;2014:201423
pubmed: 26464850
Diabetes Res Clin Pract. 2021 May;175:108776
pubmed: 33753173
Cardiovasc Diabetol. 2018 Jun 8;17(1):83
pubmed: 29884191
Diabetes Res Clin Pract. 1996 Apr;32(1-2):111-4
pubmed: 8803489
Indian J Endocrinol Metab. 2014 May;18(3):355-60
pubmed: 24944931
J Ayub Med Coll Abbottabad. 2012 Apr-Jun;24(2):87-9
pubmed: 24397062
Ann Acad Med Singap. 2006 Aug;35(8):531-5
pubmed: 17006579
Cardiovasc Diabetol. 2018 Nov 28;17(1):150
pubmed: 30486889
Diabetes Care. 2005 Mar;28(3):617-25
pubmed: 15735198
Int J Diabetes Dev Ctries. 2008 Oct;28(4):101-8
pubmed: 20165596
J Indian Med Assoc. 2013 Apr;111(4):245-7
pubmed: 24475555
Lancet Public Health. 2022 Jan;7(1):e65-e73
pubmed: 34774219
J Postgrad Med. 2014 Jul-Sep;60(3):270-5
pubmed: 25121366
Diabetes. 1989 Dec;38(12):1602-10
pubmed: 2583379
Curr Diabetes Rev. 2019;15(1):74-83
pubmed: 29366422
J Diabetes. 2013 Jun;5(2):172-9
pubmed: 23163974
Diabet Med. 2019 Dec;36(12):1629-1636
pubmed: 31094005
Kaohsiung J Med Sci. 2001 Jun;17(6):294-301
pubmed: 11559967
Endocrinol Metab Clin North Am. 2021 Sep;50(3):357-368
pubmed: 34399950
Pak J Med Sci. 2013 Jul;29(4):899-902
pubmed: 24353655
QJM. 1998 Jun;91(6):439-43
pubmed: 9709462

Auteurs

Faith Aikaeli (F)

Muhimbili Medical Research Centre, National Institute for Medical Research, Dar Es Salaam, Tanzania.

Tsi Njim (T)

Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Stefanie Gissing (S)

School of Public Health Yorkshire & Humber, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.

Faith Moyo (F)

Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Uazman Alam (U)

Institute of Life Course and Medical Sciences and the Pain Research Institute, University of Liverpool and Liverpool University Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Division of Endocrinology, Diabetes and Gastroenterology, University of Manchester, Manchester, United Kingdom.

Sayoki G Mfinanga (SG)

Muhimbili Medical Research Centre, National Institute for Medical Research, Dar Es Salaam, Tanzania.
Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Joseph Okebe (J)

Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Kaushik Ramaiya (K)

Shree Hindu Mandal Hospital, Dar es Salaam, Tanzania.

Emily L Webb (EL)

Medical Research Council International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Shabbar Jaffar (S)

Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Anupam Garrib (A)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Classifications MeSH